In xenografted tumours, curcumin upregulated the expression of TRAIL-R1/DR4, TRAIL-R2/DR5, Bax, Bak, p21/WAF1, and p27/KIP1 and inhibited the activation of NF-κB and its gene products [335]. The gene discussed is TNFRSF10B; the disease is neoplasm.